封面
市場調查報告書
商品編碼
2107873

醫藥級氫氧化鎂市場:依純度、最終用戶和地區分類。

Pharmaceutical Grade Magnesium Hydroxide Market, By Purity (<=99% and >99%), By End User (Pharmaceutical Companies, Contract Research Organizations, and Others), By Geography (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa)

出版日期: | 出版商: Coherent Market Insights | 英文 250 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

預計到 2026 年,醫藥級氫氧化鎂市場規模將達到 7.853 億美元,到 2033 年將達到 11.558 億美元。預計 2026 年至 2033 年的複合年成長率將達到 5.7%。

報告範圍 報告詳情
基準年: 2025 2026年市場規模: 7.853億美元
歷史數據時期: 2020年至2024年 預測期: 2026年至2033年
2026年至2033年預測期間的複合年成長率: 5.70% 2033年市場規模預測: 11.558億美元

藥用級氫氧化鎂,俗稱“鎂乳”,是一種超高純度的無機化合物,符合包括美國藥典 (USP) 和歐洲藥典 (EP) 在內的多種藥典的嚴格標準。此外,由於其超高純度、優異的緩衝性能和良好的安全性,該產品作為一種經濟安全的成分,被廣泛用作活性成分 (API) 或輔料,應用於包括制酸劑、瀉藥、鎂補充劑和口服製劑在內的多種產品中。

由於各種胃腸道疾病發病率的上升以及藥品和營養補充劑銷量的成長,全球藥用級氫氧化鎂市場預計將迎來顯著成長。此外,開發中國家對製藥業的投資增加、純化製程的創新以及高品質藥用原料的開發,預計也將在預測期內推動市場成長。

市場動態

受胃腸道疾病發病率上升、制酸劑、瀉藥和鎂補充劑需求增加以及醫藥和膳食補充劑行業整體成長的推動,全球藥用級氫氧化鎂市場預計將迎來顯著成長。此外,開發中國家製藥業的擴張以及藥典對高純度藥用原料和輔料標準的不斷提高,也進一步強化了對藥用級氫氧化鎂的需求。

然而,市場面臨許多限制因素,包括嚴格的監管合規要求、原料供應波動以及高能耗的生產流程。儘管如此,先進藥物製劑的研發、兒童和老年用藥需求的成長以及自我治療和非處方藥(OTC)的日益普及,都將為藥用級氫氧化鎂市場創造新的成長機會。

本次調查的主要特點

  • 本研究揭示了各個細分市場的潛在商機,並為該市場說明了一個具有吸引力的投資提案矩陣。
  • 此外,本研究還深入分析了市場促進因素、限制因素、機會、新產品發布和批准、市場趨勢、區域展望以及主要參與者採取的競爭策略。
  • 本研究根據以下參數介紹了全球藥用級氫氧化鎂市場主要公司的概況:公司概況、產品系列、主要亮點、財務表現和策略。
  • 本報告提供的見解將使企業行銷負責人和經營團隊能夠就未來的產品發布、產品升級、市場擴張和行銷策略做出明智的決策。
  • 這份「全球藥用級氫氧化鎂市場」報告旨在為產業內的各類相關人員提供參考,包括投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
  • 相關人員可以利用全球藥用級氫氧化鎂市場分析中使用的各種策略矩陣來促進決策。

目錄

第1章:研究目標與前提條件

  • 分析目的
  • 先決條件
  • 簡稱

第2章 市場展望

  • 報告說明
    • 市場定義和範圍
  • 執行摘要

第3章:市場動態、監管與趨勢分析

  • 市場動態
  • 影響分析
  • 主要亮點
  • 監管趨勢
  • 產品上市及核准
  • PEST分析
  • 波特的分析
  • 市場機遇
  • 監管趨勢
  • 產業趨勢

第4章 全球藥用級氫氧化鎂市場:依純度分類,2021-2033年

  • ≤99%
  • >99%

第5章 全球藥用級氫氧化鎂市場:依最終用戶分類,2021-2033年

  • 製藥公司
  • 受託研究機構
  • 其他

第6章 全球藥用級氫氧化鎂市場:依地區分類,2021-2033年

  • 北美洲
    • 美國
    • 加拿大
  • 拉丁美洲
    • 巴西
    • 阿根廷
    • 墨西哥
    • 其他拉丁美洲國家
  • 歐洲
    • 德國
    • 英國
    • 西班牙
    • 法國
    • 義大利
    • 俄羅斯
    • 其他歐洲國家
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 澳洲
    • 韓國
    • ASEAN
    • 其他亞太國家
  • 中東
    • 海灣合作理事會國家
    • 以色列
    • 其他中東國家
  • 非洲
    • 南非
    • 北非
    • 中非

第7章 競爭情勢

  • 公司簡介
    • Huber Engineered Materials
    • Kyowa Chemical Industry Co., Ltd.
    • Nedmag BV
    • Konoshima Chemical Co., Ltd.
    • ICL Performance Products LP
    • Martin Marietta Magnesia Specialties, LLC
    • Tateho Chemical Industries Co., Ltd.
    • ICL Group Ltd.
    • Nabaltec AG
    • UBE Corporation

第8章 分析師建議

  • 機會分析
  • 分析師意見
  • Coherent Opportunity Map

第9章 參考文獻與調查方法

  • 參考
  • 調查方法
  • 關於本公司
簡介目錄
Product Code: CMI9837

Pharmaceutical Grade Magnesium Hydroxide Market is estimated to be valued at USD 785.3 Mn in 2026 and is expected to reach USD 1,155.8 Mn by 2033, growing at a compound annual growth rate (CAGR) of 5.7% from 2026 to 2033.

Report Coverage Report Details
Base Year: 2025 Market Size in 2026: USD 785.3 Mn
Historical Data for: 2020 To 2024 Forecast Period: 2026 To 2033
Forecast Period 2026 to 2033 CAGR: 5.70% 2033 Value Projection: USD 1,155.8 Mn

Pharmaceutical grade magnesium hydroxide popularly known as milk of magnesia, is an ultra-pure inorganic compound which conform the stringent standards specified by various pharmacopoeia such as United States Pharmacopeia (USP) and European Pharmacopoeia (EP). In addition, the product finds its extensive application as active pharmaceutical ingredient (API) and an excipient in a range of applications such as antacids, laxatives, and magnesium supplements and oral formulations as an affordable and safe ingredient owing to its ultra-pure nature, effective buffering properties and benign safety profile.

The global pharmaceutical grade magnesium hydroxide market is projected to experience substantial growth owing to the surging incidences of various gastrointestinal disorders and increasing sales of pharmaceutical as well as nutraceuticals products. Growing investment in the pharmaceutical sector in various developing countries and innovation in the purification processes and development of high-quality pharmaceutical ingredients are also likely to influence the market growth over the forecasted period.

Market Dynamics

The global pharmaceutical grade magnesium hydroxide market is poised for significant growth driven by the rising prevalence of gastrointestinal disorders, coupled with the increasing demand for antacids, laxatives and magnesium supplements, and the overall growth of the pharmaceutical and nutraceutical industry. Additionally, increasing pharmaceutical manufacturing activities in developing countries and ever-increasing standards set by pharmacopeia of high purity pharmaceutical ingredients and excipients has further strengthened the demand for pharmaceutical grade magnesium hydroxide.

However, a number of constraints are present in the market, such as stringent regulatory compliance requirements, fluctuating raw material availability, and energy-intensive production processes. Nevertheless, the development of advanced pharmaceutical formulations, increasing demand for pediatric and geriatric medicines, and the growing adoption of self-medication and over-the-counter (OTC) healthcare products will offer new opportunities for growth in the pharmaceutical grade magnesium hydroxide market.

Key Features of the Study

  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global pharmaceutical grade magnesium hydroxide market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Huber Engineered Materials, Kyowa Chemical Industry Co., Ltd., Nedmag B.V., Konoshima Chemical Co., Ltd., ICL Performance Products LP, Martin Marietta Magnesia Specialties, LLC, Tateho Chemical Industries Co., Ltd., ICL Group Ltd., Nabaltec AG, and UBE Corporation
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global pharmaceutical grade magnesium hydroxide market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global pharmaceutical grade magnesium hydroxide market

Market Segmentation

  • Purity Insights (Revenue, USD Mn, 2021 - 2033)
  • <=99%
  • >99%
  • End User Insights (Revenue, USD Mn, 2021 - 2033)
  • Pharmaceutical Companies
  • Contract Research Organizations
  • Others
  • Regional Insights (Revenue, USD Mn, 2021 - 2033)
  • North America
    • U.S.
    • Canada
  • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
  • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
  • Africa
    • South Africa
    • North Africa
    • Central Africa
  • Key Players Insights
  • Huber Engineered Materials
  • Kyowa Chemical Industry Co., Ltd.
  • Nedmag B.V.
  • Konoshima Chemical Co., Ltd.
  • ICL Performance Products LP
  • Martin Marietta Magnesia Specialties, LLC
  • Tateho Chemical Industries Co., Ltd.
  • ICL Group Ltd.
  • Nabaltec AG
  • UBE Corporation

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Global Pharmaceutical Grade Magnesium Hydroxide Market, By Purity
    • Global Pharmaceutical Grade Magnesium Hydroxide Market, By End User
    • Global Pharmaceutical Grade Magnesium Hydroxide Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Product Launches/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Market Opportunities
  • Regulatory Scenario
  • Industry Trends

4. Global Pharmaceutical Grade Magnesium Hydroxide Market, By Purity, 2021-2033, (USD Mn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022 - 2033
    • Segment Trends
  • <=99%
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • >99%
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)

5. Global Pharmaceutical Grade Magnesium Hydroxide Market, By End User, 2021-2033, (USD Mn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022 - 2033
    • Segment Trends
  • Pharmaceutical Companies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Contract Research Organizations
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)

6. Global Pharmaceutical Grade Magnesium Hydroxide Market, By Region, 2021 - 2033, Value (USD Mn)

  • Introduction
    • Market Share (%) Analysis, 2026, 2029 & 2033, Value (USD Mn)
    • Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Mn)
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, By Purity, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, By Purity, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
      • Brazil
      • Argentina
      • Mexico
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, By Purity, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
      • Germany
      • U.K.
      • Spain
      • France
      • Italy
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, By Purity, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, By Purity, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
      • GCC Countries
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, By Purity, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Mn)
      • South Africa
      • North Africa
      • Central Africa

7. Competitive Landscape

  • Company Profile
    • Huber Engineered Materials
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Kyowa Chemical Industry Co., Ltd.
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Nedmag B.V.
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Konoshima Chemical Co., Ltd.
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • ICL Performance Products LP
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Martin Marietta Magnesia Specialties, LLC
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Tateho Chemical Industries Co., Ltd.
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • ICL Group Ltd.
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Nabaltec AG
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • UBE Corporation
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies

8. Analyst Recommendations

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

9. References and Research Methodology

  • References
  • Research Methodology
  • About us